Notice 27 Mar 2025 texas, drug enforcement administration, healthcare regulation, medical compliance, dea registration

⚖️DEA Revokes Registration of Texas Practitioner

The Drug Enforcement Administration has revoked the DEA registration of Willard J. Davis, D.O., due to his lack of authority to handle controlled substances in Texas following the suspension of his medical license. The decision emphasizes the need for practitioners to possess valid licenses to maintain DEA registration.

Learn More
Notice 20 Mar 2025 regulatory compliance, medical licensing, drug enforcement administration, mississippi, controlled substances

⚖️DEA Revokes Registration of Hazem Barmada, M.D. for Compliance Issues

The Drug Enforcement Administration has revoked Hazem Barmada, M.D.'s certification due to his lack of licensure in Mississippi, impacting his ability to handle controlled substances. This decision underscores the necessity for medical practitioners to maintain state compliance to retain DEA registrations and operate legally.

Learn More
Notice 26 Feb 2025 drug enforcement administration, clinical trials, regulatory compliance, controlled substances, sharp clinical services, business registration, import

💊Notice of Importer Application for Controlled Substances

Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Feb 2025 compliance, healthcare, regulation, vermont, licensing, drug enforcement administration, new hampshire

🚫Revocation of DEA Registrations

The Drug Enforcement Administration issued orders to revoke Jason Weakley R.N., A.P.R.N.'s DEA registrations due to expired state licenses in Vermont and New Hampshire. The findings indicate a lack of authority to handle controlled substances, underscoring the critical need for compliance with state laws in the healthcare sector.

Learn More
Notice 14 Feb 2025 drug enforcement administration, registration revocation, professional compliance, dental practices, public interest, healthcare regulations

🚫DEA Revocation of Registration

The decision by the Drug Enforcement Administration to revoke Robert L. Carter, D.D.S.'s DEA registration for falsifying applications raises critical compliance issues for healthcare providers. The ruling highlights the stringent standards regulating controlled substance handling and underscores the importance of maintaining integrity in application processes to ensure safeguarding public interest.

Learn More
Notice 13 Feb 2025 mylan inc., pharmaceutical industry, regulatory compliance, drug enforcement administration, controlled substances

💊Mylan Inc. Seeks Registration for Controlled Substance Importing

Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Regulatory Compliance 30 Jan 2025 regulatory compliance, information collection, department of justice, public comments, drug enforcement administration

📄DOJ Information Collection Notice for National Forensics Lab Analysis

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Regulatory Compliance, Business Operations 24 Jan 2025 controlled substances, pharmaceuticals, business compliance, import application, drug enforcement administration

💊VHG Labs Applies for Controlled Substance Import Registration

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Compliance, Regulatory 23 Jan 2025 compliance, dea, controlled substances, florida, registration revocation, drug enforcement administration, pharmacy